• Your shopping cart is empty!

Clinical Transplants 2010 Individual Chapter Downloads


Product Compare (0)


1.7 Year Follow-up After Bortezomib Therapy for Refractory Antibody Mediated Rejection.

1.7 Year Follow-up After Bortezomib Therapy for Refractory Antibody Mediated Rejection.

1.7 Year Follow-up After Bortezomib Therapy for Refractory Antibody Mediated Rejection. Shapiro..

$5.00

2010 Report from the Center for International Blood and Marrow Transplant Research (CIBMTR): Current Uses and Outcomes of Hematopoietic Cell Transplants for Blood and Bone Marrow Disorders.
A "New" Road to Tolerance: Clonal Deletion and Drugs Added When Needed (DAWN).

A "New" Road to Tolerance: Clonal Deletion and Drugs Added When Needed (DAWN).

A "New" Road to Tolerance: Clonal Deletion and Drugs Added When Needed (DAWN). Terasaki PI, Eve..

$5.00

Alternatives for Unsuccessful Living Donor Kidney Exchange Pairs.

Alternatives for Unsuccessful Living Donor Kidney Exchange Pairs.

Alternatives for Unsuccessful Living Donor Kidney Exchange Pairs. de Klerk M, Zuidema WC, IJzer..

$5.00

An Update On Antibody Reduction and Rejection Reversal Following Bortezomib Use: A Report of 52 Cases Across 10 Centers.

An Update On Antibody Reduction and Rejection Reversal Following Bortezomib Use: A Report of 52 Cases Across 10 Centers.

An Update On Antibody Reduction and Rejection Reversal Following Bortezomib Use: A Report of 52 Case..

$5.00

Bortezomib Alone Fails to Decrease Donor Specific Anti-HLA Antibodies: Even After One Year Post-treatment.

Bortezomib Alone Fails to Decrease Donor Specific Anti-HLA Antibodies: Even After One Year Post-treatment.

Bortezomib Alone Fails to Decrease Donor Specific Anti-HLA Antibodies: Even After One Year Post-trea..

$5.00

Bortezomib as an Adjuvant to Conventional Therapy in the Treatment of Antibody Mediated Rejection (AMR): The Full Spectrum.

Bortezomib as an Adjuvant to Conventional Therapy in the Treatment of Antibody Mediated Rejection (AMR): The Full Spectrum.

Bortezomib as an Adjuvant to Conventional Therapy in the Treatment of Antibody Mediated Rejection (A..

$5.00

Bortezomib as Rescue Therapy for Antibody Mediated Rejection: A Single-center Experience.

Bortezomib as Rescue Therapy for Antibody Mediated Rejection: A Single-center Experience.

Bortezomib as Rescue Therapy for Antibody Mediated Rejection: A Single-center Experience. Hardi..

$5.00

Bortezomib for Acute Humoral Rejection Treatment at the Instituto Nacional De Ciencias Médicas Y Nutrición Salvador Zubirán in Mexico City: An Update.

Bortezomib for Acute Humoral Rejection Treatment at the Instituto Nacional De Ciencias Médicas Y Nutrición Salvador Zubirán in Mexico City: An Update.

Bortezomib for Acute Humoral Rejection Treatment at the Instituto Nacional De Ciencias Médicas Y Nut..

$5.00

Bortezomib for Desensitization of Patients on a Waiting List for Deceased Donor Kidney Transplant: Experience in Mexico City.

Bortezomib for Desensitization of Patients on a Waiting List for Deceased Donor Kidney Transplant: Experience in Mexico City.

Bortezomib for Desensitization of Patients on a Waiting List for Deceased Donor Kidney Transplant: E..

$5.00

Bortezomib for the Treatment of Chronic Antibody-mediated Kidney Allograft Rejection: A Case Report.

Bortezomib for the Treatment of Chronic Antibody-mediated Kidney Allograft Rejection: A Case Report.

Bortezomib for the Treatment of Chronic Antibody-mediated Kidney Allograft Rejection: A Case Report...

$5.00

Bortezomib Use in Chronic Antibody-mediated Allograft Dysfunction: Updates and Additional Cases.

Bortezomib Use in Chronic Antibody-mediated Allograft Dysfunction: Updates and Additional Cases.

Bortezomib Use in Chronic Antibody-mediated Allograft Dysfunction: Updates and Additional Cases.&nbs..

$5.00

Clinical Islet Transplantation at the University of California, San Francisco.

Clinical Islet Transplantation at the University of California, San Francisco.

Clinical Islet Transplantation at the University of California, San Francisco. Posselt AM, Szot..

$5.00

Clinical Management of Renal Transplant Patients with Donor-specific Alloantibody: The State of the Art.

Clinical Management of Renal Transplant Patients with Donor-specific Alloantibody: The State of the Art.

Clinical Management of Renal Transplant Patients with Donor-specific Alloantibody: The State of the ..

$5.00

Columbia University/New York-Presbyterian Hospital: Improving Access to Renal Transplantation.

Columbia University/New York-Presbyterian Hospital: Improving Access to Renal Transplantation.

Columbia University/New York-Presbyterian Hospital: Improving Access to Renal Transplantation. ..

$5.00

Evolution of Graft Survival in Kidney Transplantation: An Analysis of the OPTN/UNOS Renal Transplant Registry.

Evolution of Graft Survival in Kidney Transplantation: An Analysis of the OPTN/UNOS Renal Transplant Registry.

Evolution of Graft Survival in Kidney Transplantation: An Analysis of the OPTN/UNOS Renal Transplant..

$5.00

Heart Transplantation at the Deutsches Herzzentrum Berlin.

Heart Transplantation at the Deutsches Herzzentrum Berlin.

Heart Transplantation at the Deutsches Herzzentrum Berlin. Hiemann NE, Huebler M, Lehmkuhl H, P..

$5.00

Impact of Donor-specific HLA Antibodies in Transplantation, a Review of the Literature Published in the Last Three Years.

Impact of Donor-specific HLA Antibodies in Transplantation, a Review of the Literature Published in the Last Three Years.

Impact of Donor-specific HLA Antibodies in Transplantation, a Review of the Literature Published in ..

$5.00

Improving Outcomes After Intestinal Transplantation at the University of California, Los Angeles.

Improving Outcomes After Intestinal Transplantation at the University of California, Los Angeles.

Improving Outcomes After Intestinal Transplantation at the University of California, Los Angeles.&nb..

$5.00

Kidney Paired Donation: A Single Center Approach to Increase Living Donor Transplantation.

Kidney Paired Donation: A Single Center Approach to Increase Living Donor Transplantation.

Kidney Paired Donation: A Single Center Approach to Increase Living Donor Transplantation. Bing..

$5.00

Kidney Transplantation at Necker Hospital: The Most Recent 5-year Period (2004-2009).

Kidney Transplantation at Necker Hospital: The Most Recent 5-year Period (2004-2009).

Kidney Transplantation at Necker Hospital: The Most Recent 5-year Period (2004-2009). Legendre ..

$5.00

Kidney Transplantation at UCSF: 8,300 Transplants and Onward.

Kidney Transplantation at UCSF: 8,300 Transplants and Onward.

Kidney Transplantation at UCSF: 8,300 Transplants and Onward. Wojciechowski D, Hirose R, Stock ..

$5.00

Liver Transplantation at Cleveland Clinic.

Liver Transplantation at Cleveland Clinic.

Liver Transplantation at Cleveland Clinic. Hashimoto K, Aucejo F, Quintini C, El-Gazzaz G, Hodg..

$5.00

Long-term Survival After Renal Transplantation: The Influence of Pretransplant Bilateral Nephrectomy.

Long-term Survival After Renal Transplantation: The Influence of Pretransplant Bilateral Nephrectomy.

Long-term Survival After Renal Transplantation: The Influence of Pretransplant Bilateral Nephrectomy..

$5.00

Lung and Heart Lung Transplantation at the University of Alberta 1986-2010.

Lung and Heart Lung Transplantation at the University of Alberta 1986-2010.

Lung and Heart Lung Transplantation at the University of Alberta 1986-2010. Lien DC, Weinkauf J..

$5.00

Lung Transplantation at Barnes-Jewish Hospital and Washington University in St. Louis.

Lung Transplantation at Barnes-Jewish Hospital and Washington University in St. Louis.

Lung Transplantation at Barnes-Jewish Hospital and Washington University in St. Louis. Hachem R..

$5.00

More Than 1,000 Kidney Transplants in a Single Year by the "Hospital do Rim" Group in Sao Paulo - Brazil.

More Than 1,000 Kidney Transplants in a Single Year by the "Hospital do Rim" Group in Sao Paulo - Brazil.

More Than 1,000 Kidney Transplants in a Single Year by the "Hospital do Rim" Group in Sao Paulo - Br..

$5.00

National Kidney Registry: 213 Transplants in Three Years.

National Kidney Registry: 213 Transplants in Three Years.

National Kidney Registry: 213 Transplants in Three Years. Veale J, Hil G.Clinical Transplants 2..

$5.00

One Hundred Percent Three-year Graft and Patient Survival: Kidney Transplantation at Saint Joseph Hospital of Orange.

One Hundred Percent Three-year Graft and Patient Survival: Kidney Transplantation at Saint Joseph Hospital of Orange.

One Hundred Percent Three-year Graft and Patient Survival: Kidney Transplantation at Saint Joseph Ho..

$5.00

Options for Successful Renal Transplantation in Recipients with Incompatible Living Donors: Severance Hospital Experience.

Options for Successful Renal Transplantation in Recipients with Incompatible Living Donors: Severance Hospital Experience.

Options for Successful Renal Transplantation in Recipients with Incompatible Living Donors: Severanc..

$5.00

Organ Allocation in the United Kingdom.

Organ Allocation in the United Kingdom.

Organ Allocation in the United Kingdom. Collett D, Johnson R, Hudson A, Neuberger J.Clinical Tr..

$5.00

Outcomes for Kidney Transplants at the National University Health System: Comparison with Overseas Transplants.

Outcomes for Kidney Transplants at the National University Health System: Comparison with Overseas Transplants.

Outcomes for Kidney Transplants at the National University Health System: Comparison with Overseas T..

$5.00

Reduction in Proteinuria with Bortezomib Based Therapy for Antibody Mediated Rejection.

Reduction in Proteinuria with Bortezomib Based Therapy for Antibody Mediated Rejection.

Reduction in Proteinuria with Bortezomib Based Therapy for Antibody Mediated Rejection. Lubetzk..

$5.00

Report from the National Transplantation Pregnancy Registry (NTPR): Outcomes of Pregnancy After Transplantation.

Report from the National Transplantation Pregnancy Registry (NTPR): Outcomes of Pregnancy After Transplantation.

Report from the National Transplantation Pregnancy Registry (NTPR): Outcomes of Pregnancy After Tran..

$5.00

Rescue Therapy for Acute Antibody Mediated Rejection with a Proteosome Inhibitor After Kidney Transplantation.

Rescue Therapy for Acute Antibody Mediated Rejection with a Proteosome Inhibitor After Kidney Transplantation.

Rescue Therapy for Acute Antibody Mediated Rejection with a Proteosome Inhibitor After Kidney Transp..

$5.00

Simultaneous Pancreas-Kidney Transplantation in the United States: An Analysis of the UNOS Registry.

Simultaneous Pancreas-Kidney Transplantation in the United States: An Analysis of the UNOS Registry.

Simultaneous Pancreas-Kidney Transplantation in the United States: An Analysis of the UNOS Registry...

$5.00

Targeting Alloantibody Production with Bortezomib: Does It Make More Sense?

Targeting Alloantibody Production with Bortezomib: Does It Make More Sense?

Targeting Alloantibody Production with Bortezomib: Does It Make More Sense? Lee I, Constantines..

$5.00

The 37-year Kidney Transplantation Experience at Siriraj Hospital.

The 37-year Kidney Transplantation Experience at Siriraj Hospital.

The 37-year Kidney Transplantation Experience at Siriraj Hospital.Premasathian N, Vongwiwatana A, Ta..

$5.00

The Current Trend of Induction and Maintenance Treatment in Patient of Different PRA Levels: A Report on OPTN/UNOS Kidney Transplant Registry Data.

The Current Trend of Induction and Maintenance Treatment in Patient of Different PRA Levels: A Report on OPTN/UNOS Kidney Transplant Registry Data.

The Current Trend of Induction and Maintenance Treatment in Patient of Different PRA Levels: A Repor..

$5.00

The HLA-matching Effect in Different Cohorts of Kidney Transplant Recipients: 10 Years Later.

The HLA-matching Effect in Different Cohorts of Kidney Transplant Recipients: 10 Years Later.

The HLA-matching Effect in Different Cohorts of Kidney Transplant Recipients: 10 Years Later. S..

$5.00

The Liver Transplant Program at the Charité Berlin.

The Liver Transplant Program at the Charité Berlin.

The Liver Transplant Program at the Charité Berlin. Pascher A, Neuhaus P.Clinical Transplants 2..

$5.00

Towards Kidney Allocation on Basis of HLA-DR Compatibility.

Towards Kidney Allocation on Basis of HLA-DR Compatibility.

Towards Kidney Allocation on Basis of HLA-DR Compatibility. Doxiadis II, Rahmel A, Claas FH.Cli..

$5.00

Trend in Lung Transplantation in the U.S.: An Analysis of the UNOS Registry.

Trend in Lung Transplantation in the U.S.: An Analysis of the UNOS Registry.

Trend in Lung Transplantation in the U.S.: An Analysis of the UNOS Registry. Freitas MC.Clinica..

$5.00

Using HLA Antibody Detection, Monitoring, and Treatment to Improve Long-term Allograft Survival.

Using HLA Antibody Detection, Monitoring, and Treatment to Improve Long-term Allograft Survival.

Using HLA Antibody Detection, Monitoring, and Treatment to Improve Long-term Allograft Survival.&nbs..

$5.00

Showing 1 to 44 of 44 (1 Pages)